Dabigatran-d4
| Product Name | Dabigatran-d4 |
|---|---|
| Alternate Names | Dabigatran Stable Isotopes, Stable Isotopes of Dabigatran |
| CAT No. | CS-P-07738 |
| CAS No. | 1618637-32-3 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 475.54 g/mol |
| Mol. For. | C25H21D4N7O3 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Dabigatran |
| Therapeutic | Anti-Thrombotics |
| Smileys | CN1C2=CC=C(C(N(C3=CC=CC=N3)CCC(O)=O)=O)C=C2N=C1CNC(C([2H])=C4[2H])=C(C([2H])=C4C(N)=N)[2H] |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Dabigatran-d4 is a deuterated form of dabigatran, which is an oral anticoagulant medication used for the prevention of blood clots and stroke in patients with atrial fibrillation. It is also used for the treatment and prevention of deep vein thrombosis and pulmonary embolism.
The chemical name of dabigatran-d4 is N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1,3-thiazole-5-carboxamide-d4. It has a molecular weight of 491.64 g/mol and a chemical formula of C25H25D4N6O3S.
Dabigatran-d4 inhibits the activity of thrombin, which is a key enzyme involved in the blood coagulation process. It achieves this by binding to the active site of thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is the final step in the formation of blood clots.
Dabigatran-d4 is administered orally in the form of capsules and is rapidly absorbed from the gastrointestinal tract. It has a half-life of approximately 12-17 hours and is primarily eliminated by the kidneys. Due to its high specificity for thrombin, dabigatran-d4 has fewer drug interactions compared to other anticoagulants, such as warfarin.
In conclusion, dabigatran-d4 is a deuterated form of dabigatran that is used as an anticoagulant medication for the prevention and treatment of blood clots and stroke. Its mechanism of action involves the inhibition of thrombin, and it has a high specificity and fewer drug interactions compared to other anticoagulants.
Get an Instant Quote
Related Compounds
Dabigatran D4 Etexilate | N-Nitroso Dabigatran-d4 Etexilate | Dabigatran Acyl-ß-D-glucuronide D3 trifluoroacetate salt | Deacetamidine Cyano Dabigatran-d3 Ethyl Ester Oxalate | Dabigatran Acyl-β-D-Glucuronide 13C6 | Dabigatran β-Acyl Glucuronide D4 | Dabigatran 13C6 | Deacetamidine Cyano Dabigatran-d3 Ethyl Ester | N-Nitroso Dabigatran Etexilate-d11 | N-Nitroso Dabigatran Etexilate 13C6 | Dabigatran D4 HCl | Dabigatran D7 | Dabigatran D4 DCl |